Advertisement

Picture EBD Group BioTech Showcase 2022 For Innovators 650x100
Product › Details

B. Riley Oncology Investor Conference

Products Next higher product group conference, investment / investor / financing / VC
Period Status 2021-01-21 start
Organisation Organisation B. Riley Financial Inc. (Nasdaq: RILY)
  Group B. Riley (Group)
     

Neuvogen, Inc.. (1/21/21). "Press Release: Neuvogen Announces Participation at B. Riley Virtual Oncology Investor Conference". San Diego, CA.

NEUVOGEN todayannounced that Todd Binder, Chief Executive Officer of NEUVOGEN, will participate in the B. Riley Virtual Oncology Investor Conference:

B. Riley Virtual Oncology Investor Conference
Date: Thursday, January 21, 2021
Time: 3:00 PM Eastern Time


About NEUVOGEN

NEUVOGEN, Inc. is an immunoncology company focused on whole cell cancer vaccine therapies. NEUVOGEN’s immunotherapies have the potential to deliver the broadest ever combination of tumor antigens to prime immune response. Based in San Diego, California, NEUVOGEN’s goal is to bring to market a pipeline of therapeutic cancer vaccines that activate the body’s immune system to eradicate solid tumors and meaningfully extend the lives of patients while limiting side effects generally associated with traditional cancer treatments. To learn more, visit www.neuvogen.com


NEUVOGEN Contact:

Cyrus Arman
Vice President, Corporate Development and Strategy
carman@neuvogen.com

   
Record changed: 2021-01-24

Advertisement

Picture [iito] No Content Marketing 650x100px
» Show all Events!


B. Riley Oncology Investor Conference

Past & forthcoming events


Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group BioTech Showcase 2022 For Investors 650x300




» top